Pharmacokinetics and Bioequivalence of Mirogabalin Orally Disintegrating Tablets and Conventional Tablets in Healthy Japanese Participants
This single‐center, randomized, open‐label, single‐dose, 2‐group, 2‐stage crossover trial evaluated the bioequivalence of 15 mg of mirogabalin as orally disintegrating tablets (ODTs) with conventional mirogabalin tablets in healthy Japanese men. The trial involved two studies: in Study 1, the ODT fo...
Saved in:
Published in | Clinical pharmacology in drug development Vol. 12; no. 10; pp. 985 - 990 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.10.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!